ATE250077T1 - Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung - Google Patents

Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung

Info

Publication number
ATE250077T1
ATE250077T1 AT98936825T AT98936825T ATE250077T1 AT E250077 T1 ATE250077 T1 AT E250077T1 AT 98936825 T AT98936825 T AT 98936825T AT 98936825 T AT98936825 T AT 98936825T AT E250077 T1 ATE250077 T1 AT E250077T1
Authority
AT
Austria
Prior art keywords
production
steroid sulfatase
sulfatase inhibitors
compounds
inhibitors
Prior art date
Application number
AT98936825T
Other languages
English (en)
Inventor
Pui-Kai Li
Kyle W Selcer
Original Assignee
Univ Holy Ghost Duquesne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Holy Ghost Duquesne filed Critical Univ Holy Ghost Duquesne
Application granted granted Critical
Publication of ATE250077T1 publication Critical patent/ATE250077T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98936825T 1997-07-18 1998-07-08 Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung ATE250077T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/897,247 US5880115A (en) 1997-07-18 1997-07-18 Steroid sulfatase inhibitors and methods for making and using the same
PCT/US1998/014206 WO1999003876A1 (en) 1997-07-18 1998-07-08 Steroid sulfatase inhibitors and methods for making and using the same

Publications (1)

Publication Number Publication Date
ATE250077T1 true ATE250077T1 (de) 2003-10-15

Family

ID=25407613

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98936825T ATE250077T1 (de) 1997-07-18 1998-07-08 Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung

Country Status (8)

Country Link
US (1) US5880115A (de)
EP (1) EP1009755B1 (de)
JP (1) JP2001510200A (de)
AT (1) ATE250077T1 (de)
AU (1) AU729325B2 (de)
CA (1) CA2296498A1 (de)
DE (1) DE69818278T2 (de)
WO (1) WO1999003876A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US6476011B1 (en) * 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6288050B1 (en) * 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6376687B1 (en) * 1997-07-18 2002-04-23 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
JP2002517449A (ja) 1998-06-10 2002-06-18 ステリックス リミテッド エストロンスルファターゼの阻害のための腫瘍壊死因子ａおよび２−メトキシエストロン−３−ｏ−スルファメートを有する薬学的組成物
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
JP2000309599A (ja) 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
US7078395B1 (en) 1999-06-16 2006-07-18 Sterix Limited Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling
EP1173182A2 (de) 1999-04-30 2002-01-23 Sterix Limited Verwendung von estron-derivaten als antikrebs-mittel
US7335650B2 (en) * 2000-01-14 2008-02-26 Sterix Limited Composition
US6953785B2 (en) * 2000-04-24 2005-10-11 Kyowa Hakko Kogyo Co., Ltd. Estra-1,3,5(10)-triene derivatives
GB0025788D0 (en) * 2000-10-20 2000-12-06 Sterix Ltd Use
AU2256702A (en) 2000-12-01 2002-06-11 Kyowa Hakko Kogyo Kk Composition improved in solubility or oral absorbability
WO2003009815A2 (en) 2001-07-25 2003-02-06 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US8026229B2 (en) * 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
GB0306718D0 (en) * 2003-03-24 2003-04-30 Sterix Ltd Compound
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
SG175896A1 (en) 2009-05-06 2011-12-29 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
CN111647037B (zh) * 2020-06-02 2021-12-07 南宁师范大学 17-酰胺雌甾类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE86393C (de) *
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US5556847A (en) * 1994-10-27 1996-09-17 Duquesne University Of The Holy Ghost Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5567831A (en) * 1995-08-16 1996-10-22 Duguesne University Of The Holy Ghost Non-steroidal sulfatase inhibitor compounds and their method of use

Also Published As

Publication number Publication date
DE69818278T2 (de) 2004-04-08
AU8568798A (en) 1999-02-10
WO1999003876A1 (en) 1999-01-28
JP2001510200A (ja) 2001-07-31
EP1009755B1 (de) 2003-09-17
DE69818278D1 (de) 2003-10-23
CA2296498A1 (en) 1999-01-28
EP1009755A4 (de) 2002-11-06
AU729325B2 (en) 2001-02-01
US5880115A (en) 1999-03-09
EP1009755A1 (de) 2000-06-21

Similar Documents

Publication Publication Date Title
ATE250077T1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
DE69917833D1 (de) Substituierte Karbazole, Verfahren zu ihrer Herstellung und ihre Verwendung als sPLA2- Inhibitoren
ATE233762T1 (de) Bicyclische polyamiosaure metallkomplexe, verfahren zu ihrer herstellung und ihre verwendung für medizinische bilderzeugung
DE69928697D1 (de) Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
EA200001129A3 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
NO20006645L (no) Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme
ATE128143T1 (de) 17-beta-substituierte-4-aza-5-alpha-androstan-3 one-derivate und verfahren zu ihrer herstellung.
DE69928655D1 (de) Substituierte porphyrine
DE69838146D1 (de) Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben
ATE266030T1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
ATE338056T1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und ihre verwendung
DE69632193D1 (de) Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel
MXPA05007771A (es) Procedimientos de tratamiento del dolor articular o para mejorar el sueno usando un agonista/antagonista de estrogeno.
CA2421990A1 (en) .beta.-thioamino acids
ATE282615T1 (de) Neue beta-amyloid inhibitoren, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE69819457D1 (de) Phosphorsäureester, Verfahren zu seiner Herstellung und Verwendung davon
EP0909172A4 (de) Verfahren und zusammensetzungen zur behandlung von harninkontinenz unter verwendung von enantiomer-angereichertem (r,s)-glycopyrrolat
DE50012584D1 (de) Keramikhaltiges dispergat, verfahren zu dessen herstellung und verwendung des dispergates in dickschichtpasten
ATE238779T1 (de) Steroidhaltiges pflaster, verfahren zu seiner herstellung und verwendung
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
ATE200080T1 (de) Benzoxazindionderivate, verfahren zu ihrer herstellung und ihre verwendung
DE59607683D1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE69917440D1 (de) 5-imino-13-deoxy-antracyclin-derivate, ihre verwendung sowie verfahren zu deren herstellung
ATE327227T1 (de) Klainetine und ihre derivate, verfahren zu ihrer herstellung und verwendung derselben
ATE255120T1 (de) Pluraflavine und derivate davon, verfahren zu ihrer herstellung und verwendung derselben

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties